Senate Committee Launches Asthma Inhaler Price Investigation

Legislators note that inhalers sold in USA are significantly more expensive than in other countries.

The Senate Health, Education, Labor, and Pensions (HELP) Committee sent letters this week to the CEOs of the four largest makers of inhalers in the United States, formally requesting internal communications around the pricing of their inhalers. An inhaler costs between $200 and $400 in the U.S. but is priced significantly lower in other countries, such as France and the United Kingdom, where they range between $7 and $49 per unit.

“As Chairman of the Senate HELP Committee, I am conducting an investigation into the efforts of these companies to pump up their profits by artificially inflating and manipulating the price of asthma inhalers that have been on the market for decades,” wrote Senator Bernie Sanders in the letters. The United States cannot continue to pay, by far, the highest prices in the world for prescription drugs.”

As the Lord Leads, Pray with Us…

  • For Senator Sanders and other legislators who are questioning the high prices Americans pay for prescription drugs.
  • For wisdom for the president, members of Congress, and judges in the federal judiciary as their actions impact the market, commerce, and economy of the nation.

Sources: The Hill, CNN


Back to top